Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone

Annals of Internal Medicine

Volumn 142, Issue 6, 2005, Pages

  Escobar Morreale, Héctor F ^a   Botella Carretero, José I ^a   Gómez Bueno, Manuel ^a   Galán, José M ^a   Barrios, Vivencio ^a   Sancho, José ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DEOXYPYRIDINOLINE; LEVOTHYROXINE SODIUM; LIOTRIX; THYROTROPIN; LIOTHYRONINE; THYROXINE;

ADULT; AGED; ARTICLE; BODY TEMPERATURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ECHOCARDIOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; FREE LIOTHYRONINE INDEX; HEART RATE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MOOD; NERVOUS SYSTEM FUNCTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SIDE EFFECT; STATISTICAL ANALYSIS; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; ADOLESCENT; BLOOD; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED; PATIENT SATISFACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; PATIENT SATISFACTION; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 14844339782     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-6-200503150-00007     Document Type: Article

References (40)

1. Utiger RD. Hypothyroidism. In: De Groot LJ, ed. Endocrinology. 3rd ed. Philadelphia: WB Saunders; 1995:752-68.
2. Oppenheimer JH, Schwartz HL, Mariash CN, Kinlaw WB, Wong NC, Freake HC. Advances in our understanding of thyroid hormone action at the cellular level. Endocr Rev. 1987;8:288-308. [PMID: 3308445]
3. Morreale de Escobar G. Conversion of T4 to T3 and its relation to hormonal activity. In: Reinwein D, ed. Regulation of Thyroid Function, vol 1. Stuttgart: F.K. Schattaner Verlag; 1976:109-29.
4. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest. 1995;96:2828-38. [PMID: 8675653]
5. Escobar-Morreale HF, Escobar del Rey F, Obregón MJ, de Escobar G Escobar. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology. 1996;137:2490-502. [PMID: 8641203]
6. Smith RN, Taylor SA, Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. Br Med J. 1970;4:145-8. [PMID: 4097650]
7. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340:424-9. [PMID: 9971866]
8. Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol. 2000;3:167-174. [PMID: 11343593]
9. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;88:4543-50. [PMID: 14557419]
10. Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003;290:2952-8. [PMID: 14665656]
11. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003; 88:4551-5. [PMID: 14557420]
12. Kaplan MM, Sarne DH, Schneider AB. In search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients [Editorial]. J Clin Endocrinol Metab. 2003;88:4540-2. [PMID: 14557418]
13. Toft AD. Thyroid hormone replacement-one hormone or two? [Editorial]. N Engl J Med. 1999;340:469-70. [PMID: 9971874]
14. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R. Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. Am J Physiol. 1990;258:E715-26. [PMID: 2333963]
15. Botella-Carretero JI, Gomez-Bueno M, Barrios V, Caballero C, Garcia-Robles R, Sancho J, et al. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. Endocr Relat Cancer. 2004;11:345-56. [PMID: 15163309]
16. Zulewski H, Muller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab. 1997;82:771-6. [PMID: 9062480]
17. McNair D, Lorr M, Droppleman L. POMS Manual Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1992.
18. Alonso J, Anto JM, Moreno C. Spanish version of the Nottingham Health Profile: translation and preliminary validity. Am J Public Health. 1990;80:704-8. [PMID: 2343954]
19. Alonso J, Prieto L, Anto JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Qual Life Res. 1994;3:385-93. [PMID: 7866356]
20. Alonso J, Regidor E, Barrio G, Prieto L, Rodriguez C, de la Fuente L. [Population reference values of the Spanish version of the Health Questionnaire SF-36]. Med Clin (Barc). 1998;111:410-6. [PMID: 9834913]
21. Bullinger M, Alonso J, Apolone G, Leplege A, Sullivan M, Wood-Dauphinee S, et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:913-23. [PMID: 9817108]
22. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ. 1993;306:1440-4. [PMID: 8518640]
23. Wechsler D. WAIS-R Manual: Wechsler Adult Intelligence Scale-Revised. New York: Harcourt Brace Jovanovich; 1981.
24. Kaplan E, Fein D, Morris R, Delis D. WAIS-R NI as a Neuropsychological Instrument. San Antonio, TX: Psychological Corp.; 1991.
25. Weintraub S, Mesulam M. Mental state assessment of young and elderly adults in behavioral neurology. In: Mesulam MM, ed. Principles of Behavioral Neurology. Philadelphia: FA Davis; 1985:71-122.
26. Wechsler D. Escala de Inteligencia de Wechsler para Adultos-III. Madrid: TEA Ediciones, S.A.; 1999.
27. Botelk-Carretero JI, Galán JM, Caballero C, Sancho J, Escobar-Morreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer. 2003;10:601-10. [PMID: 14713270]
28. Celesia GG, Brigell MG. Recommended standards for pattern electroretinograms and visual evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999;52:53-67. [PMID: 10590976]
29. Pratt H, Aminoff M, Nuwer MR, Starr A. Short-latency auditory evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999;52:69-77. [PMID: 10590977]
30. Tudor G, Koch GG. Review of nonparametric methods for the analysis of crossover studies. Stat Methods Med Res. 1994;3:345-81. [PMID: 7889227]
31. Fleiss JL. The Crossover Study. The Design and Analysis of Clinical Experiments. New York: J Wiley; 1986:263-90.
32. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, Morreale de Escobar G. Tissue-specific patterns of changes in 3,5,3′-triiodo-L- thyronine concentrations in thyroidectomized rats infused with increasing doses of the hormone. Which are the regulatory mechanisms? Biochimie. 1999;81:453-62. [PMID: 10403175]
33. Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, et al. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf). 2004;60:750-7. [PMID: 15163340]
34. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on 'adequate' doses of 1-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002;57:577-85. [PMID: 12390330]
35. Ladenson PW. Psychological wellbeing in patients. Clin Endocrinol (Oxf). 2002;57:575-6. [PMID: 12390329]
36. Cooper DS. Combined T4 and T3 therapy-back to the drawing board [Editorial]. JAMA. 2003;290:3002-4. [PMID: 14665664]
37. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987;316:764-70. [PMID: 3821822]
38. LeBoff MS, Kaplan MM, Silva JE, Larsen PR. Bioavailabiliry of thyroid hormones from oral replacement preparations. Metabolism. 1982;31:900-5. [PMID: 7121261]
39. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid. 2004;14:271-5. [PMID: 15142360]
40. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L, Prange AJ Jr. Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine. 2002;18:129-33. [PMID: 12374459]